Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

被引：2
|
作者：
van Mulligen, Elise [1 ,2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2333 ZA Leiden, Netherlands
[2] Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands
来源：
LANCET RHEUMATOLOGY | 2024年 / 6卷 / 05期
关键词：
D O I：
10.1016/S2665-9913(24)00038-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e254 / e255
页数：2
相关论文
共 50 条
  • [41] Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
    Burkard, Theresa
    Williams, Ross D.
    Vallejo-Yaguee, Enriqueta
    Huegle, Thomas
    Finckh, Axel
    Kyburz, Diego
    Burden, Andrea M.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (03)
  • [42] Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission
    Baker, Kenneth F.
    Mcdonald, David
    Hulme, Gillian
    Hussain, Rafiqul
    Coxhead, Jonathan
    Swan, David
    Schulz, Axel R.
    Mei, Henrik E.
    Macdonald, Lucy
    Pratt, Arthur G.
    Filby, Andrew
    Anderson, Amy E.
    Isaacs, John D.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [43] PREDICTORS OF DRUG-FREE REMISSION FOLLOWING TREATMENT WITH ABATACEPT (IN COMBINATION WITH METHOTREXATE OR AS MONOTHERAPY) IN EARLY RHEUMATOID ARTHRITIS
    Emery, Paul
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Combe, Bernard G.
    Furst, Daniel E.
    Karyekar, Chetan S.
    Wong, Dennis A.
    Huizinga, Tom W. J.
    RHEUMATOLOGY, 2015, 54 : 28 - 29
  • [44] Predictors of Drug-Free Remission Following Treatment with Abatacept (in Combination with Methotrexate or as Monotherapy) in Early Rheumatoid Arthritis
    Emery, P.
    Burmester, Gerd
    Bykerk, Vivian P.
    Combe, B.
    Furst, D. E.
    Barre, E.
    Karyekar, C. S.
    Wong, D.
    Huizinga, T. W. J.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1084 - S1084
  • [45] TAPERING TOWARDS DMARD-FREE REMISSION IN ESTABLISHED RHEUMATOID ARTHRITIS: 2 YEAR RESULTS OF THE TARA TRIAL
    Van Mulligen, E.
    Weel, A.
    Kuijper, M.
    Hazes, J.
    Van der Helm-Van Mil, A.
    De Jong, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 631 - 632
  • [46] TAPERING DMARDS IN THE TREACH TRIAL - FLARE RATES, SUSTAINED REMISSION AND RADIOLOGICAL PROGRESSION
    Kuijper, T.
    Luime, J.
    de Jong, P.
    Gerards, A.
    van Zeben, D.
    Tchetverikov, I.
    de Sonnaville, P.
    van Krugten, M.
    Grillet, B.
    Hazes, J.
    Weel, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 76 - 76
  • [47] Sustained DMARD-free remission in rheumatoid arthritis - about concepts and moving towards practice
    Verstappen, Marloes
    JOINT BONE SPINE, 2022, 89 (06)
  • [48] ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Bykerk, V. P.
    Burmester, G. R.
    Combe, B. G.
    Furst, D. E.
    Huizinga, T. W. J.
    Wong, D. A.
    Emery, P.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 42 - 42
  • [49] SHORT-TERM CLINICAL OUTCOME AND ULTRASONOGRAPHIC-SYNOVITIS DYNAMICS IN RHEUMATOID ARTHRITIS PATIENTS IN DMARDS-INDUCED SDAI REMISSION UNDER DRUG-FREE CONDITIONS
    Manzo, A.
    Benaglio, F.
    Sakellariou, G.
    Scarabelli, M.
    Binda, E.
    Vitolo, B.
    Bugatti, S.
    Caporali, R.
    Montecucco, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 263 - 263
  • [50] Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Vivian P. Bykerk
    Gerd R. Burmester
    Bernard G. Combe
    Daniel E. Furst
    Tom W. J. Huizinga
    Harris A. Ahmad
    Paul Emery
    Rheumatology International, 2019, 39 : 945 - 945
12345